European Association of Urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)
M Babjuk, M Burger, O Capoun, D Cohen… - European urology, 2022 - Elsevier
Abstract Context The European Association of Urology (EAU) has released an updated
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …
European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update
M Babjuk, M Burger, EM Compérat, P Gontero… - European urology, 2019 - Elsevier
Context This overview presents the updated European Association of Urology (EAU)
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …
Recurrence mechanisms of non-muscle-invasive bladder cancer—A clinical perspective
Non-muscle-invasive bladder cancer (NMIBC) is an early-stage cancer without invasion into
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
the detrusor muscle layer. Transurethral resection of bladder tumour (TURBT) is a diagnostic …
Heating technology for malignant tumors: A review
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia,
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline
SS Chang, SA Boorjian, R Chou, PE Clark… - The Journal of …, 2016 - auajournals.org
Purpose: Although associated with an overall favorable survival rate, the heterogeneity of
non-muscle invasive bladder cancer (NMIBC) affects patients' rates of recurrence and …
non-muscle invasive bladder cancer (NMIBC) affects patients' rates of recurrence and …
Magnetic hyperthermia: Potentials and limitations
Despite the fact that the magnetic hyperthermia (MH) has been known for more than 75
years, it is still debated in its clinical applications. The generation of a higher temperature at …
years, it is still debated in its clinical applications. The generation of a higher temperature at …
Review on magnetic nanoparticle-mediated hyperthermia for cancer therapy
Biocompatible magnetic nanoparticle-mediated magnetic hyperthermia is an innovative,
efficient, and safer thermo-therapeutic approach for cancer treatment. Structural and …
efficient, and safer thermo-therapeutic approach for cancer treatment. Structural and …
Biologically targeted magnetic hyperthermia: Potential and limitations
Hyperthermia, the mild elevation of temperature to 40–43° C, can induce cancer cell death
and enhance the effects of radiotherapy and chemotherapy. However, achievement of its full …
and enhance the effects of radiotherapy and chemotherapy. However, achievement of its full …
European association of Urology guidelines on non–muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ)—A summary of the 2024 guidelines update
P Gontero, A Birtle, O Capoun, E Compérat… - European Urology, 2024 - Elsevier
Background and objective This publication represents a summary of the updated 2024
European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer …
European Association of Urology (EAU) guidelines for non–muscle-invasive bladder cancer …
Bladder cancer
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not
treated optimally. Awareness of haematuria as the major presenting symptom is paramount …
treated optimally. Awareness of haematuria as the major presenting symptom is paramount …